MEDICINES CO's ticker is and the CUSIP is 584688AE5. A total of 42 filers reported holding MEDICINES CO in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2019 | $4,521,000 | +25.0% | 3,000,000 | 0.0% | 0.18% | +37.4% |
Q2 2019 | $3,618,000 | +20.1% | 3,000,000 | 0.0% | 0.13% | +12.9% |
Q1 2019 | $3,013,000 | +16.4% | 3,000,000 | 0.0% | 0.12% | -4.9% |
Q4 2018 | $2,589,000 | -19.9% | 3,000,000 | 0.0% | 0.12% | +4.3% |
Q3 2018 | $3,231,000 | -11.7% | 3,000,000 | 0.0% | 0.12% | -17.0% |
Q2 2018 | $3,660,000 | +5.7% | 3,000,000 | 0.0% | 0.14% | -4.7% |
Q1 2018 | $3,462,000 | +9.2% | 3,000,000 | 0.0% | 0.15% | +2.8% |
Q4 2017 | $3,171,000 | -16.6% | 3,000,000 | 0.0% | 0.14% | -17.7% |
Q3 2017 | $3,801,000 | -2.9% | 3,000,000 | 0.0% | 0.18% | -11.6% |
Q2 2017 | $3,913,000 | -17.5% | 3,000,000 | 0.0% | 0.20% | -27.7% |
Q1 2017 | $4,744,000 | +31.4% | 3,000,000 | 0.0% | 0.27% | +13.2% |
Q4 2016 | $3,611,000 | -7.4% | 3,000,000 | 0.0% | 0.24% | -0.8% |
Q3 2016 | $3,898,000 | +9.8% | 3,000,000 | 0.0% | 0.24% | -7.2% |
Q2 2016 | $3,549,000 | +4.2% | 3,000,000 | 0.0% | 0.26% | -7.7% |
Q1 2016 | $3,405,000 | – | 3,000,000 | – | 0.28% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Worth Venture Partners, LLC | 4,201,000 | $4,842,000 | 4.21% |
Cheyne Capital Management (UK) LLP | 5,000,000 | $5,773,000 | 2.61% |
SILVERBACK ASSET MANAGEMENT LLC | 11,000,000 | $12,690,000 | 2.49% |
DLD Asset Management, LP | 22,500,000 | $26,072,000 | 2.35% |
Myriad Asset Management Ltd. | 15,000,000 | $17,301,000 | 1.55% |
BASSO CAPITAL MANAGEMENT, L.P. | 5,551,000 | $6,387,000 | 1.18% |
TFG Asset Management GP Ltd | 5,000,000 | $5,830,000 | 0.90% |
WOLVERINE ASSET MANAGEMENT LLC | 46,660,000 | $53,798,000 | 0.70% |
CSS LLC/IL | 10,983,000 | $12,651,000 | 0.63% |
Castle Creek Arbitrage, LLC | 6,000,000 | $6,920,000 | 0.51% |